Mabwell Biotech Deploys WMS & WCS Systems with Synchronized Computerized System Validation (CSV) by Hippocrates

I. Smart Warehousing Plus Compliance‑Oriented Validation: Consolidating the Cornerstone for Antibody Drug Industrialization

Mabwell Biotech recently announced the completion of smart warehousing system upgrades at its large‑scale commercial production bases in Jinshan, Shanghai and Taizhou, Jiangsu. The project covers the deployment of Fullon WMS (Warehouse Management System), Dematic WCS (Warehouse Control System) and Huihuan WS Weighing System, together with end‑to‑end Computerized System Validation (CSV) launched in partnership with Hippocrates. This combined solution represents Mabwell Biotech’s dual‑track model of “system implementation plus validation assurance” for the industrialization of antibody and recombinant protein drugs, closing the digital loop ranging from raw material receiving to finished‑goods shipment.

As an innovative biopharmaceutical enterprise that starts with target discovery and molecular discovery for antibody drugs, Mabwell Biotech covers the full R&D cycle including druggability study, pre‑clinical research, clinical research and manufacturing translation. It has built industrialization bases for antibody and recombinant protein drugs compliant with GMP standards of China NMPA, US FDA and EU EMA. Faced with industry pain points including stringent batch traceability requirements for antibody drugs, complex coordination between cold storage and high‑bay warehouses, and high anti‑error standards for weighing operations, the enterprise adopted WMS & WCS as core systems and rolled out CSV validation concurrently, to ensure efficient digital transformation within compliance boundaries.

II. WMS & WCS: Leap from Manual Warehouse Management to Smart Warehousing Hub

The implementation of Fullon WMS and Dematic WCS at Mabwell Biotech is far more than a simple upgrade of warehousing tools. It represents a management revolution covering cold storage, high‑bay warehouses and weighing workflows. Its value is reflected in three key scenarios:

Scenario 1: Second‑level Scheduling for Cold Storage‑High‑bay Warehouse Coordination

• Pain points: Cold storage and high‑bay warehouses were previously operated under separate management. Material transfers relied on manual document handover. Batch change‑over took dozens of minutes on average, accompanied by risks of cold‑chain temperature breakage.
• Outcomes: WCS centrally dispatches AGVs and hoists, boosting intra‑warehouse transfer efficiency by 50%‑70%. Cold‑room temperature fluctuation is controlled within ±1 °C, and material batch‑switching duration is reduced to less than 10 minutes.

Scenario 2: Mistake‑proofing and End‑to‑end Traceability for Weighing Processes

• Smart weighing: The WS Weighing System conducts real‑time interconnection with WMS. Material identities are verified via barcode scanning, and weighing parameters from process recipes are automatically matched. If weighing deviation exceeds the threshold, the system locks operations immediately and triggers QA review.
• Global traceability: Material batch numbers are bound to production work orders. Reverse traceability back to raw‑material suppliers and full cold‑chain transportation records can be completed within minutes, meeting FDA and EMA full‑traceability requirements for biological products.

Scenario 3: Unified Data Network via Multi‑system Integration

• Interface enablement: WMS achieves seamless connection with ERP, LIMS, EBR (Electronic Batch Record) and EAM (Enterprise Asset Management) through the ESB data lake. Material status, QC results and batch record information are synchronized in real time.
• Inventory accuracy: Post‑go‑live inventory physical‑to‑system consistency rate exceeds 99.9%. The identification cycle for slow‑moving materials is shortened from monthly to daily.

III. Hippocrates CSV Validation: From Compliance Conformance to Risk Immunity

Under dual regulatory pressures from FDA 21 CFR Part 11 and EU GMP Annex 11, Mabwell Biotech engaged Hippocrates for CSV services. A three‑layer defense system was built for WMS, WCS, WS systems as well as cross‑system interfaces:

Defense Layer 1: Regulation‑Oriented Penetration Testing

• Simulated FDA unannounced audit scenarios to verify whether system functions such as audit trails and electronic signatures comply with 21 CFR Part 11, with focus on the originality and non‑repudiation of weighing data.
• Tests on cold‑storage temperature data tamper‑resistant capabilities against EU GMP Annex 11 requirements achieved a 100% vulnerability remediation rate.
• Completed 21 CFR Part 11 applicability assessment and conformance assessment to guarantee legal validity of electronic records and electronic signatures.

Defense Layer 2: Stability Under Extreme Stress Testing

• During peak‑concurrency access and 72‑hour continuous‑operation tests, WMS response latency was less than 2 seconds, and WCS scheduling instruction execution accuracy stood above 99.9%.
• Network outage recovery tests demonstrated over 99.9% completeness of business data restoration, with zero loss of weighing data.

Defense Layer 3: Closed‑loop Full‑lifecycle Validation

• In strict accordance with the GAMP 5 V‑model, full‑process validation was completed covering URS, functional risk assessment, design qualification and IQ/OQ/PQ, delivering more than twenty validation documents.
• Code review and unit‑to‑integration testing were performed for the hybrid architecture consisting of 4 categories of configurable software and 5 categories of customized software, to ensure compliance of custom‑built interfaces.
• A Requirement Traceability Matrix (RTM) was established to realize bidirectional traceability from user requirements to test cases.

IV. Strategic Value: Smart Warehousing Accelerates Antibody Drug Industrialization

Multi‑dimensional business breakthroughs have been achieved after project roll‑out:

• Efficiency: Overall warehouse operational efficiency improved by 40%‑50%; weighing error rate dropped by 80%‑90%, generating annual labor‑cost savings of over RMB 1 million.
• Quality: Inventory physical‑to‑system consistency rate rose above 99.9%; cold‑chain temperature deviation incidents decreased by 80%‑90%, with zero data‑integrity observations in FDA inspections.
• Market readiness: Supported by complete electronic data chains and validation frameworks, multiple international audits have been successfully passed, laying a compliance foundation for Mabwell’s antibody drug commercialization in the EU and US markets.

“Smart warehousing systems are not cost centers, but infrastructure for quality assurance. Hippocrates’ CSV validation granted us a compliance passport upon system go‑live, which is critical for innovative biopharma enterprises.” — Manufacturing Lead, Mabwell Biotech

Through deep integration of WMS & WCS implementation and Hippocrates‑delivered CSV, Mabwell Biotech has not only set a benchmark for smart warehousing in antibody drug manufacturing, but also demonstrated an efficient industry‑proven path of “parallel system deployment and validation”. Where smart warehousing meets rigorous validation, this innovative biopharma enterprise is writing a new compliance paradigm for biomanufacturing industrialization.

V. Related Solutions

Hippocrates Computerized System Validation (CSV) Consulting Services

VI. Related Case

WMS & WCS System Validation Project for Jiangsu Zhongbang Pharmaceutical